A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm
This study has been completed.
Sponsor:
Teva Pharmaceutical Industries
Collaborator:
Cetero Research, San Antonio
Information provided by:
Teva Pharmaceutical Industries
ClinicalTrials.gov Identifier:
NCT00964730
First received: August 21, 2009
Last updated: April 6, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2010 |
| Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |